Skip to main content

Peer Review reports

From: lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p

Original Submission
6 May 2022 Submitted Original manuscript
22 May 2022 Reviewed Reviewer Report - Abhishek Basu
25 May 2022 Reviewed Reviewer Report
25 May 2022 Reviewed Reviewer Report
8 Jun 2022 Reviewed Reviewer Report - Ankit Tanwar
24 Jun 2022 Author responded Author comments - Yi Peng
Resubmission - Version 2
24 Jun 2022 Submitted Manuscript version 2
29 Jun 2022 Author responded Author comments - Yi Peng
Resubmission - Version 3
29 Jun 2022 Submitted Manuscript version 3
30 Jun 2022 Author responded Author comments - Yi Peng
Resubmission - Version 4
30 Jun 2022 Submitted Manuscript version 4
10 Jul 2022 Reviewed Reviewer Report - Abhishek Basu
11 Jul 2022 Reviewed Reviewer Report - Ankit Tanwar
13 Jul 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
13 Jul 2022 Editorially accepted
27 Jul 2022 Article published 10.1186/s12860-022-00432-7

You can find further information about peer review here.

Back to article page